US 11098025
Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
granted A61KA61K45/06A61P
Quick answer
US patent 11098025 (Bi-functional compounds and methods for targeted ubiquitination of androgen receptor) held by Montelino Therapeutics Inc. expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Montelino Therapeutics Inc.
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K45/06, A61P, A61P13/08, A61P35/00